These ASX 200 shares could rise 25% to 60%

Brokers are tipping these shares to deliver outsized returns for investors.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are hunting for big returns for your investment portfolio, then look no further than the ASX 200 shares in this article.

That's because analysts are tipping them to rise by 25%+ over the next 12 months. Here's what you need to know about them:

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.

Image source: Getty Images

Flight Centre Travel Group Ltd (ASX: FLT)

The team at Macquarie thinks that this travel agent giant is a cheap ASX 200 share to buy right now.

While it wasn't blown away with its full year results in FY 2025, it believes its valuation is attractive and expects improvements in macro conditions to drive strong performances from its key segments. It said:

Outperform. While profit disappointed, both segments delivered solid TTV growth which should accelerate if macro conditions are more supportive. Valuation is attractive, and we see material upside to the current share price over a 12m view.

Macquarie has an outperform rating and $16.55 price target on Flight Centre's shares. Based on its current share price of $13.03, this implies potential upside of 27% for investors over the next 12 months.

In addition, it is forecasting a fully franked dividend yield of 3% in FY 2026, which boosts the total potential return to 30%.

Telix Pharmaceuticals Ltd (ASX: TLX)

Analysts at Bell Potter think that big returns could be coming for patient investors with this beaten down radiopharmaceuticals company's shares.

Although it concedes that this year has been tough for approvals (most recently the denial of Zircaix by the US FDA), it remains very positive on its longer term outlook and appears to see the recent share price weakness as a buying opportunity. It said:

The previous forecast included modest revenues from Zircaix in FY26 ($31m) which is now stripped out and EBITDA is reduced by $13m. The company does not plan to curtail any R&D spend at this point as it remains well capitalised and we expect will continue to generate cash from operations. This is the second CRL for TLX this calendar year. The delay to revenues and knock on effect to the cost of capital (risk) and valuation are material, accordingly our TP is reduced.

Bell Potter has put a buy rating and $23.00 price target on the ASX 200 share. Based on its current share price of $14.60, this suggests that upside of almost 60% is possible for investors between now and this time next year.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Telix Pharmaceuticals. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Flight Centre Travel Group and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Comical investor reading documents and surrounded by calculators.
Broker Notes

4 ASX 200 shares newly upgraded this week

As the Iran war and fuel crisis continues, some ASX 200 shares have attracted upgrades from the experts.

Read more »

A smiling woman puts fuel into her car at a petrol pump.
Broker Notes

Up 60% in a year, 3 reasons to buy Ampol shares today

A leading analyst forecasts more outperformance from Ampol’s surging shares. But why?

Read more »

Smiling worker in metal landfill.
Broker Notes

Up 45% in a year, 3 reasons to buy Sims shares today

A leading analyst forecasts more outperformance from Sims' soaring share price. But why?

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

Bell Potter names more of the best ASX shares to buy in April

The broker has good things to say about the shares this month.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

2 ASX shares downgraded by Morgans this week

Let's see what the broker is saying about these two names.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

Should you buy Boss Energy shares for uranium exposure?

The team at Bell Potter has given its verdict on this uranium producer.

Read more »

A man leans forward propped on his elbows as he holds his clasped hands to his mouth in a worried pose as he gazes at his computer screen in a home setting.
Broker Notes

Buy, hold, sell: Bank of Queensland, Koala, and Westpac shares

Let's see what analysts at Morgans are saying about these shares.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Why this ASX 200 share could be heading 40%+ higher

Looking for big returns? Bell Potter thinks this stock could be a buy.

Read more »